Carmell (NASDAQ:CTCX) Shares Up 6.3%

Carmell Co. (NASDAQ:CTCXGet Free Report)’s share price shot up 6.3% during mid-day trading on Tuesday . The stock traded as high as $2.45 and last traded at $2.20. 3,120 shares traded hands during trading, a decline of 50% from the average session volume of 6,222 shares. The stock had previously closed at $2.07.

Carmell Stock Performance

The firm has a 50 day moving average price of $2.74 and a two-hundred day moving average price of $2.95.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Hubbell Strickland Wealth Management LLC bought a new position in Carmell in the 1st quarter worth about $32,000. Cookson Peirce & Co. Inc. purchased a new position in shares of Carmell during the 3rd quarter valued at about $54,000. Linden Advisors LP purchased a new position in shares of Carmell during the 3rd quarter valued at about $270,000. Carnegie Mellon University purchased a new position in Carmell in the 3rd quarter worth approximately $371,000. Finally, Meteora Capital LLC purchased a new position in Carmell in the 3rd quarter worth approximately $6,416,000. Institutional investors own 24.22% of the company’s stock.

Carmell Company Profile

(Get Free Report)

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of a potent cocktail of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.

Further Reading

Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.